隔离的四肢输液可以避免截肢指示在最初不可挽救的四肢瘤
Jan Lesensky1, Ondrej Blecha1, Ana C Belzarena2
1Department of Orthopaedics, First Medical Faculty, Charles University, University Hospital Na Bulovce, Prague, Czech Republic.
Clinical orthopaedics and related research
|June 19, 2025
概括
用瘤亡因子α和梅尔法兰 (TM-ILP) 隔离的肢体输液为无法切除的软组织肉瘤提供了一种节省肢体的选择,在12个月内截肢率为13%,没有重大早期并发症. 这种方法显示了令人鼓舞的生存率和挑战极端肉瘤的局部控制.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 药理学 药理学是指药理学的学科.
背景情况:
- 软组织肉瘤是具有有限治疗选择的侵袭性癌症.
- 用瘤亡因子α和梅尔法兰 (TM-ILP) 隔离的肢体 perfusion 提供局部高剂量化疗,最大限度地降低全身毒性.
- 在经验有限的中心中,TM-ILP的可行性和肢体救援影响需要进一步调查.
研究的目的:
- 评估在TM-ILP后12个月对最初无法挽救的瘤进行截肢的累积发病率.
- 确定在TM-ILP后30天内出现严重早期并发症的患者比例.
- 评估TM-ILP后的全因生存率和局部无复发生存率.
主要方法:
- 对34名患有软组织瘤的患者进行了回顾性观察性研究,这些患者被认为不适合肢体挽救.
- 管理了TM-ILP,随后对肢体救援手术进行了重新评估.
- 分析了无截肢生存率,严重并发症,全因生存率和局部无复发生存率.
主要成果:
- 截肢的12个月累计发病率为13%,最初无法切除的病变.
- 没有观察到任何主要的早期并发症 (死亡,隔间综合征,因反应而导致的截肢).
- 12个月全因生存率为77%,局部无复发生存率为93%.
结论:
- TM-ILP促进了边缘切除四肢肉瘤的节能手术.
- 早期的结果表明TM-ILP是为选定的患者提供一个有前途的选择.
- 需要进行更长的随访时间的大型研究,以确认TM-ILP在肉瘤护理中的作用.
相关概念视频
01:23Peripheral Artery Disease V: Postoperative Nursing Management
28
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
28
01:27Peripheral Artery Disease III: Interprofessional Care
34
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
34